Bristol-Myers Squibb Co (BMY)

NYSE · Pharmaceuticals

67.66
+0.74 (+1.11%)
Updated Sep 3, 1:55 AM ET
AI Rating
Strong Buy
Overall Score
80
Trend
100
Momentum
54
Risk
83

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 21, 2025 260 sessions Sep 2, 2026

AI Analysis

Bristol-Myers Squibb Co is trading at $67.66, up 1.11% on the session. The 50 day average sits at $62.41 and the 200 day at $57.93, which puts the stock in a uptrend. RSI is at 62.4, which reads as strong, and MACD is bearish crossover. Volume is below average.

The nearest support is around $63.20 with resistance near $68.05, so that band frames the current range. Average daily movement is roughly $1.50, or about 2.2% of the share price, which is what any stop placement has to allow for. The overall health score of 80 out of 100 combines a trend score of 100, momentum of 54 and a risk score of 83.

Technical indicators

RSI (14)
62.4
strong
MACD
1.354
bearish crossover
SMA 20
65.90
SMA 50
62.41
SMA 200
57.93
uptrend
ATR (14)
1.50
avg daily range
Support
63.20
Resistance
68.05
Volume vs 20d
0.88x
below average
Volatility
22.6%
annualised
1 month
+2.69%
3 months
+23.65%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.